Methenolone Enanthate
Status
No approved product. No FDA-approved labeling exists in the United States. Methenolone has been marketed in some other countries. Schedule III controlled substance.
What it is
A mild DHT-derived injectable steroid with limited modern clinical data.
What published research measured
A dihydrotestosterone-derived anabolic steroid available in injectable enanthate and oral acetate forms, with a limited clinical history in anaemia and wasting states, mostly outside the United States. It does not aromatize. Its notable structural point is that the oral form is not 17-alpha-alkylated but 1-methylated, which means it lacks the specific hepatotoxicity pattern of the alkylated orals — though oral bioavailability is correspondingly poor and the oral form requires much higher exposure for the same effect. It is a comparatively weak anabolic agent, and it suppresses endogenous testosterone production despite the reputation for mildness that surrounds it. Prohibited at all times under WADA class S1.1.
Source
Hussain Z et al. 2016 — Aspergillus niger-mediated biotransformation of methenolone enanthate, and immunomodulatory activity of its transform… · Kennedy BJ et al. 1968 — Effect of methenolone enanthate (NSC-64967) in advanced cancer of the breast · Menon DK. 2003 — Successful treatment of anabolic steroid-induced azoospermia with human chorionic gonadotropin and human menopausal g…
Sources
No linked primary source is on file for this entry yet.
Educational use only, never medical advice. No doses.